Jan Wålinder

4.3k total citations
91 papers, 3.0k citations indexed

About

Jan Wålinder is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Jan Wålinder has authored 91 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 18 papers in Clinical Psychology and 17 papers in Pharmacology. Recurrent topics in Jan Wålinder's work include Treatment of Major Depression (14 papers), LGBTQ Health, Identity, and Policy (12 papers) and Schizophrenia research and treatment (11 papers). Jan Wålinder is often cited by papers focused on Treatment of Major Depression (14 papers), LGBTQ Health, Identity, and Policy (12 papers) and Schizophrenia research and treatment (11 papers). Jan Wålinder collaborates with scholars based in Sweden, Slovenia and United States. Jan Wålinder's co-authors include Wolfgang Rutz, Lars von Knorring, Bengt Lundström, Mikael Landén, Patrick Sourander, Jan Balldin, Hans Forssman, Jöns Lundmark, Ingvar Karlsson and Ann‐Kathrine Granérus and has published in prestigious journals such as The Lancet, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Jan Wålinder

90 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Wålinder Sweden 32 1.0k 1.0k 791 427 315 91 3.0k
J.P. Lépine France 30 1.5k 1.5× 809 0.8× 1.4k 1.7× 534 1.3× 187 0.6× 62 3.8k
Marc Ansseau Belgium 30 891 0.9× 592 0.6× 592 0.7× 527 1.2× 94 0.3× 131 3.4k
William R. Yates United States 42 1.7k 1.7× 541 0.5× 941 1.2× 376 0.9× 93 0.3× 139 4.6k
M Casacchia Italy 36 1.2k 1.2× 413 0.4× 2.0k 2.5× 327 0.8× 282 0.9× 183 4.0k
Juan J López-Ibor Spain 28 1.4k 1.3× 560 0.6× 1.7k 2.2× 329 0.8× 147 0.5× 113 3.6k
Ilan Modai Israel 33 1.1k 1.1× 532 0.5× 1.6k 2.0× 259 0.6× 95 0.3× 114 3.4k
M. Ansseau Belgium 23 553 0.5× 656 0.7× 431 0.5× 302 0.7× 106 0.3× 109 2.2k
L. G. Kiloh Australia 25 602 0.6× 308 0.3× 1.1k 1.4× 644 1.5× 253 0.8× 63 3.1k
C. Perris Sweden 37 2.6k 2.6× 1.1k 1.1× 2.5k 3.2× 672 1.6× 164 0.5× 237 6.0k
Daniel J. Luchins United States 40 1.2k 1.1× 416 0.4× 2.1k 2.6× 210 0.5× 165 0.5× 147 4.4k

Countries citing papers authored by Jan Wålinder

Since Specialization
Citations

This map shows the geographic impact of Jan Wålinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Wålinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Wålinder more than expected).

Fields of papers citing papers by Jan Wålinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Wålinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Wålinder. The network helps show where Jan Wålinder may publish in the future.

Co-authorship network of co-authors of Jan Wålinder

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Wålinder. A scholar is included among the top collaborators of Jan Wålinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Wålinder. Jan Wålinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pålhagen, Sven, et al.. (2009). HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment. Journal of Neurology. 256(9). 1510–1518. 16 indexed citations
2.
Pålhagen, Sven, Hongshi Qi, Björn Mårtensson, et al.. (2009). Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression. Journal of Neurology. 257(4). 524–532. 63 indexed citations
3.
Reis, Margareta, Gunilla Olsson, Björn Carlsson, et al.. (2002). Serum Levels of Citalopram and Its Main Metabolites in Adolescent Patients Treated in a Naturalistic Clinical Setting. Journal of Clinical Psychopharmacology. 22(4). 406–413. 16 indexed citations
4.
Eriksson, Tomas & Jan Wålinder. (1998). Amitriptyline and Clomipramine Increase the Concentration of Administered L-Tryptophan in the Rat Brain. Journal of Pharmacy and Pharmacology. 50(10). 1133–1137. 7 indexed citations
5.
Landén, Mikael, Jan Wålinder, & Bengt Lundström. (1998). Clinical characteristics of a total cohort of female and male applicants for sex reassignment: a descriptive study. Acta Psychiatrica Scandinavica. 97(3). 189–194. 40 indexed citations
6.
Landén, Mikael, Jan Wålinder, & Bengt Lundström. (1996). Prevalence, incidence and sex ratio of transsexualism. Acta Psychiatrica Scandinavica. 93(4). 221–223. 94 indexed citations
7.
Rutz, Wolfgang, Lars von Knorring, Hans Pihlgren, Z. Ríhmer, & Jan Wålinder. (1995). An educational project on depression and its consequences: is the frequency of major depression among Swedish men underrated, resulting in high suicidality?. 1. 59. 27 indexed citations
8.
Bengtsson, Boel, B.‐E. Wiholm, M Myrhed, & Jan Wålinder. (1994). Adverse experiences during treatment with zimeldine on special licence in Sweden. International Clinical Psychopharmacology. 9(1). 55–62. 4 indexed citations
9.
Balldin, Jan, et al.. (1994). Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake. Drug and Alcohol Dependence. 35(3). 245–248. 12 indexed citations
10.
11.
Rutz, Wolfgang, Lars von Knorring, & Jan Wålinder. (1992). Long‐term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatrica Scandinavica. 85(1). 83–88. 282 indexed citations
12.
Balldin, Jan, et al.. (1992). Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal. Biological Psychiatry. 31(7). 712–719. 26 indexed citations
13.
Rutz, Wolfgang, Per Carlsson, Lars von Knorring, & Jan Wålinder. (1992). Cost‐benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatrica Scandinavica. 85(6). 457–464. 66 indexed citations
14.
Zhu, Jie, et al.. (1992). Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats. Journal of Neuroimmunology. 39(1-2). 109–122. 30 indexed citations
15.
Rutz, Wolfgang, Lars von Knorring, Jan Wålinder, & B. Wistedt. (1990). Effect of an educational program for general practitioners on Gotland on the pattern of prescription of psychotropic drugs. Acta Psychiatrica Scandinavica. 82(6). 399–403. 56 indexed citations
16.
Lundmark, Jöns, et al.. (1989). Paroxetine: pharmacokinetic and antidepressant effect in the elderly. Acta Psychiatrica Scandinavica. 80(S350). 76–80. 43 indexed citations
17.
Rutz, Wolfgang, Jan Wålinder, G. Eberhard, et al.. (1989). An educational program on depressive disorders for general practitioners on Gotland: background and evaluation. Acta Psychiatrica Scandinavica. 79(1). 19–26. 107 indexed citations
18.
Wålinder, Jan & Arvid Carlsson. (1973). Potentiation of neuroleptics by catecholamine inhibitors.. BMJ. 1(5852). 551.4–552. 6 indexed citations
19.
Wålinder, Jan. (1967). Transsexualism : a study of forty-three cases. Gothenburg University Publications Electronic Archive (Gothenburg University). 57 indexed citations
20.
Ekblom, Bengt & Jan Wålinder. (1965). BLOOD-DYSCRASIA AFTER THIORIDAZINE. The Lancet. 286(7401). 36–36. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.P. Lépine Breakdown of academic impact, for papers by Marc Ansseau Breakdown of academic impact, for papers by William R. Yates Breakdown of academic impact, for papers by M Casacchia Breakdown of academic impact, for papers by Juan J López-Ibor Breakdown of academic impact, for papers by Ilan Modai Breakdown of academic impact, for papers by M. Ansseau Breakdown of academic impact, for papers by L. G. Kiloh Breakdown of academic impact, for papers by C. Perris Breakdown of academic impact, for papers by Daniel J. Luchins
Rankless by CCL
2026